Mallinckrodt Pharma IP Trading Dac
100 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Recorded as renamed to Mallinckrodt Pharma IP Trading Unlimited (2023)
5
Ending by 2030
Dec 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 4 terms have ended since Aug 23, 2026
- Nov 2 US 11,124,767 Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells · term ended
- Oct 16 US 10,099,029 Systems and Methods of Administering a Pharmaceutical Gas to a Patient · lapsed on the fee record
- Sep 30 US 8,846,105 Dry Powder Fibrin Sealant · lapsed on the fee record
- Sep 16 US 8,835,416 High-Purity Large-Scale Preparation of Stannsoporfin · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,675,378 | Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same In force · High confidence | In force | High confidence | |
| US 11,246,938 | Hemostatic Microspheres In force · High confidence | In force | High confidence | |
| US 10,328,176 | Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same In force · Low confidence | In force | Low confidence | |
| US 10,722,610 | Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same In force · High confidence | In force | High confidence | |
| US 11,478,569 | Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 100 patents in force now held by others · 24 lapsed for an unpaid fee · 63 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 abandoned